•
Mar 31, 2023

ImmunityBio Q1 2023 Earnings Report

Total Revenue
$360K
Previous year: $14K
+2471.4%
EPS
-$0.27
Previous year: -$0.26
+3.8%
Gross Profit
-$5.92M
Previous year: -$5.39M
+9.7%
Cash and Equivalents
$88.5M
Previous year: $36.4M
+143.2%
Free Cash Flow
-$92.7M
Previous year: -$102M
-9.3%
Total Assets
$343M
Previous year: $390M
-11.9%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment